These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1646653)

  • 1. Evaluation of automated enzyme immunoassays for several markers for hepatitis A and B using the Abbott IMx analyser.
    Fayol V; Ville G
    Eur J Clin Chem Clin Biochem; 1991 Jan; 29(1):67-70. PubMed ID: 1646653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis of acute viral hepatitis A or B by microparticle enzyme immunoassay.
    Chernesky MA; Crawford J; Castriciano S; Mahony JB
    J Virol Methods; 1991 Oct; 34(3):291-6. PubMed ID: 1744219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the fully automated Cobas Core enzyme immunoassay for the quantitation of antibodies against hepatitis B virus surface antigen.
    Doche C; Thomé M; Dimet I; Bienvenu J
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):365-8. PubMed ID: 8704055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers.
    Miedouge M; Legrand-Abravanel F; Lalanne C; Saune K; Izopet J
    J Clin Virol; 2009 Feb; 44(2):134-7. PubMed ID: 19110466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
    Lyra LG
    Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassays.
    Eble K; Clemens J; Krenc C; Rynning M; Stojak J; Stuckmann J; Hutten P; Nelson L; DuCharme L; Hojvat S
    J Med Virol; 1991 Mar; 33(3):139-50. PubMed ID: 1880494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relapses and reinfections in viral hepatitis: an analysis of repeated admissions].
    Frolov AF; Fedorchenko SV; Vozianova SV
    Ter Arkh; 1990; 62(11):11-5. PubMed ID: 1965616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
    Taylor P; Pickard G; Gammie A; Atkins M
    J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiple centre clinical study of third-generation enzyme immunoassays for hepatitis B surface antigen and hepatitis B core IgM class antibody.
    Jakob R
    Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):259-66. PubMed ID: 8318575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of "anti HBC alone" serological profile in 284 patients suspicious of being infected with hepatitis B virus].
    Berrajah-Fki L; Ben Halima S; Guermazi F; Hammami A; Karray-Hakim H
    Ann Biol Clin (Paris); 2006; 64(5):451-5. PubMed ID: 17040876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of incidence of biological markers for A and B hepatitis].
    Zalewska M; Gładysz A; Molin I
    Pol Tyg Lek; 1991 Apr 1-15; 46(14-16):271-3. PubMed ID: 1669050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of clinical laboratory data in the differential diagnosis of group hepatitis B diseases].
    Orgel' MIa; Tychinskiĭ NV; Rogotskaia LT; Reznikov AP; Muliar IS; Sapego ZhK
    Vrach Delo; 1991 Mar; (3):40-3. PubMed ID: 1645896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
    van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Practical remarks regarding the analysis of markers of acute viral hepatitis].
    Oszczak A; Maciejewska E
    Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):283-4. PubMed ID: 1332002
    [No Abstract]   [Full Text] [Related]  

  • 15. [IgM class antibodies against hepatitis A viruses in the differentiation of viral hepatitis].
    Zivanović-Marinković V; Stanković D; Parabucki S; Lazarov A; Marinković V; Krstić L; Letica Z
    Zb Vojnomed Akad; 1982; 24():24-7. PubMed ID: 6765185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of hepatitis B markers in previously diagnosed hepatitis patients during a one-year period].
    Poyraz O; Gökoğlu M; Oztop Y
    Mikrobiyol Bul; 1993 Oct; 27(4):314-20. PubMed ID: 8264444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT anti-HBc assay: analysis of borderline reactive sera.
    Ollier L; Laffont C; Kechkekian A; Doglio A; Giordanengo V
    J Virol Methods; 2008 Dec; 154(1-2):206-9. PubMed ID: 18848582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
    Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
    Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.